Browsing Tag
Alzheimer’s Drug Discovery Foundation
2 posts
AviadoBio opens fourth ASPIRE-FTD cohort as AVB-101 regains full development rights and secures fresh backing from leading dementia foundations
AviadoBio opens the fourth ASPIRE-FTD cohort, regains full AVB-101 rights from Astellas, and secures ADDF backing. Read what it means for FTD gene therapy.
March 31, 2026
Astrocyte Pharmaceuticals secures over $6m for brain injury treatments
Astrocyte Pharmaceuticals Inc., a vanguard in the realm of cerebroprotective drug discovery, has amassed over $6 million in…
August 20, 2023